Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00706810
What this trial is testing

Combination of Hydroxyurea and Verapamil for Refractory Meningiomas

Who this might be right for
CancerBrain CancerMeningioma
University of Utah 8
Large-scale testing (Phase 3)Not Yet RecruitingNCT07551479
What this trial is testing

SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)MSS (Microsatellite Stable)
Fudan University 612
Not applicableStudy completedNCT01395303
What this trial is testing

Polymorphisms in the Vitamin D System and Health

Who this might be right for
InfarctionStrokeDiabetes+4 more
University of Tromso 9,700
Testing effectiveness (Phase 2)Study completedNCT02804750
What this trial is testing

Study to Evaluate CORT125134 in Participants With Cushing's Syndrome

Who this might be right for
Cushing's Syndrome
Corcept Therapeutics 35
Testing effectiveness (Phase 2)Study completedNCT01081223
What this trial is testing

Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma

Who this might be right for
GliomaHigh Grade AstrocytomaGlioblastoma Multiforme
TVAX Biomedical 12
Testing effectiveness (Phase 2)Study completedNCT02847559
What this trial is testing

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Who this might be right for
Anaplastic (Malignant) MeningiomaAtypical MeningiomaGrade II Meningioma+3 more
Northwestern University 20
Not applicableStudy completedNCT04232059
What this trial is testing

The Effect of Different Ventilation Strategies on Cerebral Oxygenation Using Near Infrared Spectroscopy (NIRS) in Pediatrics Undergoing Posterior Fossa Tumor Surgery

Who this might be right for
Infratentorial NeoplasmsHyperventilationCraniotomy
Kasr El Aini Hospital 42
Testing effectiveness (Phase 2)Study completedNCT00431561
What this trial is testing

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Who this might be right for
GlioblastomaAnaplastic Astrocytoma
Isarna Therapeutics GmbH 141
Not applicableTemporarily pausedNCT04217525
What this trial is testing

Duke Spine Outcome Study (DSOS)

Who this might be right for
Spinal TumorSpinal Disorder
Duke University 900
Not applicableLooking for participantsNCT06358625
What this trial is testing

Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Center Eugene Marquis 120
Not applicableLooking for participantsNCT05033691
What this trial is testing

Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases

Who this might be right for
NSCLCEGFR Gene MutationEGF-R Positive Non-Small Cell Lung Cancer+2 more
Hadassah Medical Organization 162
Early research (Phase 1)Study completedNCT00503724
What this trial is testing

Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Pediatric Brain Tumor Consortium 32
Not applicableLooking for participantsNCT07463625
What this trial is testing

Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors.

Who this might be right for
Cushing DiseaseACTH-producing Pituitary Tumour
Hospices Civils de Lyon 20
Not applicableUnknownNCT04831190
What this trial is testing

A Tailored Exercise Oncology Program for Neuro-Oncology Patients

Who this might be right for
CancerBrain Tumor, Primary
University of Calgary 70
Large-scale testing (Phase 3)Looking for participantsNCT05768490
What this trial is testing

Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain Metastases

Who this might be right for
Brain MetastasesRadiotherapyEGFR Activating Mutation
Sun Yat-sen University 232
Early research (Phase 1)Active Not RecruitingNCT02191488
What this trial is testing

ALA-induced PpIX Fluorescence During Brain Tumor Resection

Who this might be right for
Brain Tumors
David W. Roberts 540
Testing effectiveness (Phase 2)WithdrawnNCT02876003
What this trial is testing

Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma

Who this might be right for
Glioblastoma
GenSpera, Inc.
Not applicableStudy completedNCT05448690
What this trial is testing

Comparative Effectiveness of Different Surgical Approaches for Giant Pituitary Adenomas

Who this might be right for
SurgeryPituitary Adenoma
Huashan Hospital 600
Early research (Phase 1)Study completedNCT00006246
What this trial is testing

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorLeukemia+4 more
Pediatric Brain Tumor Consortium 28
Not applicableStudy completedNCT00052286
What this trial is testing

Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer

Who this might be right for
Brain and Central Nervous System TumorsCognitive/Functional EffectsFatigue
Jonsson Comprehensive Cancer Center 29
Next Page